BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20191351)

  • 1. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
    Ivic B; Ibric S; Betz G; Zorica D
    Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of diclofenac sodium release from matrix pellets compressed into MUPS tablets.
    Ivić B; Ibrić S; Betz G; Djurić Z
    Yakugaku Zasshi; 2009 Nov; 129(11):1375-84. PubMed ID: 19881210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized regression neural networks in prediction of drug stability.
    Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
    J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
    Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
    Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of dynamic neural networks in the modeling of drug release from polyethylene oxide matrix tablets.
    Petrović J; Ibrić S; Betz G; Parojcić J; Durić Z
    Eur J Pharm Sci; 2009 Sep; 38(2):172-80. PubMed ID: 19632323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G.
    Ivić B; Ibrić S; Cvetković N; Petrović A; Trajković S; Djurić Z
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):947-9. PubMed ID: 20606343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melt extrusion bioadhesive delivery of diclofenac sodium granules using theobroma oil.
    Attama AA; Adikwu MU
    Boll Chim Farm; 2004 May; 143(4):174-7. PubMed ID: 15255341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles.
    Bertocchi P; Antoniella E; Valvo L; Alimonti S; Memoli A
    J Pharm Biomed Anal; 2005 Apr; 37(4):679-85. PubMed ID: 15797788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of matrix tablets controlled drug release using Elman dynamic neural networks and decision trees.
    Petrović J; Ibrić S; Betz G; Đurić Z
    Int J Pharm; 2012 May; 428(1-2):57-67. PubMed ID: 22402474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report: in vitro dissolution studies of different brands of sustained release diclofenac sodium matrix tablet available in Bangladesh.
    Abdullah MD; Bepary S; Rouf AS
    Pak J Pharm Sci; 2008 Jan; 21(1):70-7. PubMed ID: 18166523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
    Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro-in vivo evaluation of double layer coated and matrix sustained release pellet formulations of diclofenac potassium.
    Fu J; Wang X; Xu L; Meng J; Weng Y; Li G; He H; Tang X
    Int J Pharm; 2011 Mar; 406(1-2):84-90. PubMed ID: 21219996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac sodium loaded gelatin magnetic microspheres for intra-arterial administration: formulation, characterization and in vitro release studies.
    Saravanan M; Bhaskar K; Narayanan NV; Maharajan G; Pillai KS
    Boll Chim Farm; 2003 Oct; 142(8):347-51. PubMed ID: 15040465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of controlled-release diclofenac microspheres and tabletted microspheres.
    Vilivalam VD; Adeyeye CM
    J Microencapsul; 1994; 11(4):455-70. PubMed ID: 7931945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation.
    Parojcić J; Ibrić S; Djurić Z; Jovanović M; Corrigan OI
    Eur J Pharm Sci; 2007 Mar; 30(3-4):264-72. PubMed ID: 17188851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.